Business Wire

U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the ...
Medindia

How Some People Defeat Dengue Without Getting Sick

A new study maps how the immune system clears dengue without symptoms, revealing protective responses that could guide safer, ...
Business Wire

Dengue Vaccines Market 2016-2019: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Dengue Vaccines: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug ...
Mena FN

Dengue Fever Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Johnson & Johnson, Novartis Pharmaceuticals, Merck Sharp & Dohme ...

"Dengue Fever Clinical Trials"DelveInsight's,“Dengue Fever - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Dengue Fever pipeline landscape ...
Nature

Cardiovascular manifestations of the emerging dengue pandemic

The majority of dengue virus infections are mild; only a small proportion of patients develop overt complications, which can include systemic vascular leak syndrome, bleeding, and organ impairment ...